Christine Dolan - 30 Apr 2024 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)

Role
Executive Vice President & General Manager, Cygnus Technologies
Signature
/s/ Kurt Oreshack, by power of attorney for Christine Dolan
Issuer symbol
MRVI
Transactions as of
30 Apr 2024
Net transactions value
+$2,753
Form type
4
Filing time
02 May 2024, 18:46:09 UTC
Previous filing
18 Mar 2024
Next filing
12 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRVI Class A Common Stock Award $2,753 +483 +0.19% $5.70 258,490 30 Apr 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is voluntarily reporting the acquisition of shares of the Issuer's Class A Common Stock pursuant to the Maravai LifeSciences Holdings, Inc. 2020 Employee Stock Purchase Plan. The acquisition of those 483 shares of Class A Common Stock was exempt pursuant to Rule 16b-3.

Remarks:

Executive Vice President & General Manager, Cygnus Technologies